Profile

Cytox

Cytox is developing a diagnostic test and therapeutic cures for Alzheimer’s Disease which is estimated to affect 15 million people worldwide. The company is a university spin-out based on groundbreaking academic research into the role of the cell cycle in neuro-degenerative diseases.

Status current

Associated Fund Advantage Growth Fund,
Rainbow Seed Fund

Sector Medical / Biotechnology

Website www.cytoxgroup.com

Associated Team Members

Relevant News

Cytox Plans US Clinical Launch for Early-Stage Alzheimer's Test While Courting Pharma Partners

  May 03, 2017 Justin Petrone www.genomeweb.com British molecular diagnostics company Cytox plans to make…

read more

Cytox raises £2.6m led by Catapult Ventures to launch predictive...

Investment will help commercialize Cytox’s services for testing for Alzheimer’s disease and grow Cytox...

read more

Cytox’s breakthrough polygenic risk scoring approach for assessing Alzheimer’s disease...

Cytox’s breakthrough polygenic risk scoring approach for assessing Alzheimer’s disease risk poised to accelerate...

read more

More Companies in Medical / Biotechnology